SEC Filings HubLive
Live feed
Filing

Form 3

Form 3
0001193125-26-401301·ADARx Pharmaceuticals, Inc.

Filing metadata

Accession number
0001193125-26-401301
Form type
Form 3
Filer
ADARx Pharmaceuticals, Inc.
CIK
CIK 1802369
Filed
Sep 24, 2026
Reporting period
Sep 24, 2026
Description
Initial ownership

Documents

Filed by